Report: FDA may lift hold on Geron's stem cell trial by early 2009

10/20/2008 |

The FDA may lift its hold on Geron's study involving the use of embryonic stem cells in treating spinal cord damage by early 2009, according to a report from The Scientist. The agency placed the trial on hold in May, saying it needed to work out how to regulate therapies based on stem cells.

View Full Article in:

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA